相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
Adam S. Darwich et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients with a Wide Range of Body Weight
Christine Wegler et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters
Brahim Achour et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail
Camille Lenoir et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Exploring the Use of Serum-Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting Polypeptides
A. David Rodrigues et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal Cancer
Rohan Gupta et al.
ONCOLOGIST (2020)
Virtual Twins: Understanding the Data Required for Model-Informed Precision Dosing
Thomas M. Polasek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Characterization of CYP2B6 K262R allelic variants by quantitative allele-specific proteomics using a QconCAT standard
Jill Barber et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure
Andrew Rowland et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
From Endogenous Compounds as Biomarkers to Plasma-Derived Nanovesicles as Liquid Biopsy; Has the Golden Age of Translational Pharmacokinetics-Absorption, Distribution, Metabolism, Excretion-Drug-Drug Interaction Science Finally Arrived?
David Rodrigues et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Emerging Role of Precision Medicine in Cardiovascular Disease
Jane A. Leopold et al.
CIRCULATION RESEARCH (2018)
PharmGKB: A worldwide resource for pharmacogenomic information
Julia M. Barbarino et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2018)
Precision dosing in clinical medicine: present and future
Thomas M. Polasek et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact
Daniel Gonzalez et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma
Yasunori Matsumoto et al.
ONCOLOGY REPORTS (2016)
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
Richard B. Lanman et al.
PLOS ONE (2015)
Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
M. Bosilkovska et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma
Marija Bosilkovska et al.
BIOANALYSIS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem
Kathrin Klein et al.
Frontiers in Genetics (2013)
Analysis of exosome release and its prognostic value in human colorectal cancer
J. Silva et al.
GENES CHROMOSOMES & CANCER (2012)
Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models
Eleanor J. Guest et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Ulf Diczfalusy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Evaluation of 227 drugs for in vitro inhibition of cytochrome P4502B6
Robert L. Walsky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
分享论文
